BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36682930)

  • 1. Prevalence and Predictability of Occult Satellite Nodules in Clinical Stage Ia Non-small Cell Lung Cancer following Lobectomy.
    Kneuertz PJ; Abdel-Rasoul M; D'Souza DM; Moffatt-Bruce SD; Merritt RE
    Clin Lung Cancer; 2023 May; 24(3):e134-e140. PubMed ID: 36682930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wedge Resection vs Lobectomy for Clinical Stage IA Non-Small Cell Lung Cancer With Occult Lymph Node Disease.
    Kneuertz PJ; Abdel-Rasoul M; D'Souza DM; Moffatt-Bruce SD; Merritt RE
    Ann Thorac Surg; 2023 Jun; 115(6):1344-1351. PubMed ID: 36126718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after video-assisted thoracic surgery (VATS) lobectomy versus lobectomy via open thoracotomy for clinical stage IA non-small cell lung cancer.
    Higuchi M; Yaginuma H; Yonechi A; Kanno R; Ohishi A; Suzuki H; Gotoh M
    J Cardiothorac Surg; 2014 May; 9():88. PubMed ID: 24886655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Population-Based Study of Outcomes in Surgically Resected T3N0 Non-Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm.
    Blaauwgeers H; Damhuis R; Lissenberg-Witte BI; de Langen AJ; Senan S; Thunnissen E
    J Thorac Oncol; 2019 Mar; 14(3):459-467. PubMed ID: 30408568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer.
    Jeon HW; Kim YD; Kim KS; Sung SW; Park HJ; Park JK
    World J Surg Oncol; 2014 Jul; 12():215. PubMed ID: 25027055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Node-Positive Segmentectomy for Non-Small-Cell Lung Cancer: Risk Factors and Outcomes.
    Lutfi W; Schuchert MJ; Dhupar R; Ekeke C; Sarkaria IS; Christie NA; Luketich JD; Okusanya OT
    Clin Lung Cancer; 2019 Jul; 20(4):e463-e469. PubMed ID: 31031205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases.
    Stephens N; Rice D; Correa A; Hoffstetter W; Mehran R; Roth J; Walsh G; Vaporciyan A; Swisher S
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):607-13. PubMed ID: 24603446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
    Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
    Clin Lung Cancer; 2021 Jul; 22(4):e574-e583. PubMed ID: 33234491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
    Speicher PJ; Gu L; Gulack BC; Wang X; D'Amico TA; Hartwig MG; Berry MF
    Clin Lung Cancer; 2016 Jan; 17(1):47-55. PubMed ID: 26602547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
    Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
    Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer.
    Ou SH; Zell JA
    J Thorac Oncol; 2008 Aug; 3(8):880-6. PubMed ID: 18670306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
    Moon Y; Choi SY; Park JK; Lee KY
    World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.